PA(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)) (BioCAD00000109374)
{$topic}
Metabolite Card
Formula: C41H71O8P (722.4886)
SMILES: [H][C@@](COC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC)(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC
Synonyms [en]
PA(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)); 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-2-(9Z-octadecenoyl)-glycero-3-phosphate; 1-(5Z,8Z,11Z,14Z)-Eicosatetraenoyl-2-(9Z)-octadecenoyl-sn-glycero-3-phosphate; 1-C20:4(omega-6)-2-C18:1(omega-9)-phosphatidylic acid; 1-(5Z,8Z,11Z,14Z)-Icosatetraenoyl-2-(9Z)-octadecenoyl-sn-glycero-3-phosphate; 1-(5Z,8Z,11Z,14Z-Eicosatetraenoyl)-2-(9Z-octadecenoyl)-glycero-3-phosphoric acid
Last reviewed on 2024-06-28.
Cite this Page
PA(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)). 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China.
https://biocad_registry.innovation.ac.cn/s/(-)-arctiin
(retrieved
2026-01-03) (CAD Registry RN: BioCAD00000109374). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Note
PA(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)), in particular, consists of one chain of arachidonic acid at the C-1 position and one chain of oleic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
DBLinks
- CAS Registry Number:
- PubChem CID: 52929222
- ChEBI: 75141
- HMDB: HMDB0115151
- LipidMaps: LMGP10010629
- KEGG:
- BioCyc:
- NCBI MeSH:
- Wikipedia:
Other DBLinks
- PubChem: 52929222
- ChEBI: ChEBI:75141
- HMDB: HMDB0115151
- LipidMaps: LMGP10010629
- RefMet: RM0133513
- Metlin: METLIN_81795
Class / Ontology
- WishartLab ClassyFire: [Glycerophosphates] Glycerophosphates
- RefMet: [PA] PA
- LipidMaps: [Diacylglycerophosphates [GP1001]] Diacylglycerophosphates [GP1001]
- ChEBI: [CHEBI:75141] 1-arachidonoyl-2-oleoyl-sn-glycero-3-phosphate
Taxonomy Source
Pathway Synthetic
| pathway id | name |
|---|---|
| PathBank:SMP0024816 | De Novo Triacylglycerol Biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) |
| PathBank:SMP0024820 | De Novo Triacylglycerol Biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/18:4(6Z,9Z,12Z,15Z)) |
| PathBank:SMP0029659 | Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) |
| PathBank:SMP0029663 | Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z)) |
| PathBank:SMP0029667 | Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)) |
| PathBank:SMP0029671 | Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)) |
| PathBank:SMP0029675 | Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z)) |
| PathBank:SMP0072076 | Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)) |
| PathBank:SMP0072080 | Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)) |
| PathBank:SMP0072084 | Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)) |
| PathBank:SMP0072088 | Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z)) |
| PathBank:SMP0072092 | Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z)) |
| PathBank:SMP0079858 | Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)) |
| PathBank:SMP0079862 | Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z)) |
| PathBank:SMP0079866 | Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z)) |
| PathBank:SMP0079870 | Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)) |
| PathBank:SMP0079874 | Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) |
| PathBank:SMP0016137 | De Novo Triacylglycerol Biosynthesis TG(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) |
| PathBank:SMP0095130 | Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) |
| PathBank:SMP0095134 | Cardiolipin Biosynthesis CL(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z)) |